REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 91 filers reported holding REVOLUTION MEDICINES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,305,236 | +17.2% | 155,536 | +13.3% | 0.00% | +50.0% |
| Q2 2023 | $3,673,631 | +25.3% | 137,332 | +1.4% | 0.00% | 0.0% |
| Q1 2023 | $2,932,201 | +31.1% | 135,374 | +44.9% | 0.00% | +100.0% |
| Q4 2022 | $2,236,015 | +28.8% | 93,394 | +5.4% | 0.00% | 0.0% |
| Q3 2022 | $1,736,415 | +7.8% | 88,598 | +5.6% | 0.00% | 0.0% |
| Q2 2022 | $1,610,787 | -24.3% | 83,869 | +0.7% | 0.00% | 0.0% |
| Q1 2022 | $2,128,917 | +171.5% | 83,272 | +170.0% | 0.00% | – |
| Q4 2021 | $784,000 | -6.3% | 30,844 | +1.3% | 0.00% | -100.0% |
| Q3 2021 | $837,000 | -19.9% | 30,440 | -7.6% | 0.00% | 0.0% |
| Q2 2021 | $1,045,000 | -2.8% | 32,928 | +40.5% | 0.00% | 0.0% |
| Q1 2021 | $1,075,000 | +20.9% | 23,432 | +4.3% | 0.00% | 0.0% |
| Q4 2020 | $889,000 | +23.1% | 22,458 | +8.2% | 0.00% | 0.0% |
| Q3 2020 | $722,000 | +177.7% | 20,748 | +144.0% | 0.00% | – |
| Q2 2020 | $260,000 | – | 8,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |